{
    "title": "Regeneron's COVID drug sales outside U.S. help revenue beat",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-10781763/Regeneron-quarterly-profit-drops-COVID-antibody-sales-hit.html",
    "date": "2022-05-04",
    "keywords": [
        "drug",
        "dupixent",
        "quarter",
        "growth",
        "revenue",
        "eylea",
        "roche",
        "regeneron",
        "analyst",
        "company",
        "covid19",
        "antibody",
        "demand",
        "blockbuster",
        "partnership",
        "brand",
        "name",
        "limit",
        "setback",
        "market",
        "food",
        "administration",
        "use",
        "effectiveness",
        "omicron",
        "coronavirus",
        "drugmaker",
        "generation",
        "omicronlineage",
        "collaboration",
        "topline",
        "beat",
        "mohit",
        "bansal",
        "note",
        "premarket",
        "trade",
        "estimate",
        "refinitiv",
        "treatment",
        "degeneration",
        "partner",
        "sanofi",
        "sa",
        "peak",
        "target",
        "march",
        "profit",
        "year",
        "reporting",
        "leo",
        "bengaluru",
        "editing",
        "rashmi",
        "aich",
        "shinjini",
        "ganguli"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}